Anticoagulation Therapy and NOACs in Heart Failure.

about

Anticoagulation Therapy and NOACs in Heart Failure.

Item

http://www.wikidata.org/entity/Q39148821

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Anticoagulation Therapy and NOACs in Heart Failure.

@en

Anticoagulation Therapy and NOACs in Heart Failure.

@nl

type

Item

label

Anticoagulation Therapy and NOACs in Heart Failure.

@en

Anticoagulation Therapy and NOACs in Heart Failure.

@nl

prefLabel

Anticoagulation Therapy and NOACs in Heart Failure.

@en

Anticoagulation Therapy and NOACs in Heart Failure.

@nl

P1476

Anticoagulation Therapy and NOACs in Heart Failure.

@en

P2093

Barry Greenberg

http://www.w3.org/2001/XMLSchema#string

Isac Thomas

http://www.w3.org/2001/XMLSchema#string

Jorge EncisoSilva

http://www.w3.org/2001/XMLSchema#string

Michelle Schlueter

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

Atrial fibrillation and stroke : concepts and controversies

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

P304

515-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2016_126

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28233177

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

anticoagulation